Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cost Effectiveness of Two Different Strategies to Implement the NVOG Guideline Programme on Subfertility
Brief Summary: The purpose of this study is to compare two different strategies to implement the existing Guideline programme on Subfertility, as issued by the Dutch Society of Obstetrics and Gynaecology (NVOG). Therefore, an innovative patient-directed strategy will be compared to a control strategy and effectiveness, costs and feasibility of both strategies will be assessed.


Options:
A: Arm Label: Training; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: No Training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Training
B: Arm Label: minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: professional audit and feedback (guideline adherence) | Arm Label: maximal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: patient education, Behavioral: professional audit and feedback (guideline adherence), Behavioral: professional education (communication/shared decision making), Other: information tools | Intervention Type: BEHAVIORAL; Name: patient education; Assigned to Arm(s): maximal intervention | Intervention Type: BEHAVIORAL; Name: professional audit and feedback (guideline adherence); Assigned to Arm(s): maximal intervention, minimal intervention | Intervention Type: BEHAVIORAL; Name: professional education (communication/shared decision making); Assigned to Arm(s): maximal intervention | Intervention Type: OTHER; Name: information tools; Assigned to Arm(s): maximal intervention
C: Arm Label: GSK257049 [5-17M] Group; Type: EXPERIMENTAL; Interventions: Biological: Malaria Vaccine 257049, Biological: Meningococcal C Conjugate Vaccine | Arm Label: GSK257049 [6-12W] Group; Type: EXPERIMENTAL; Interventions: Biological: Malaria Vaccine 257049, Biological: Meningococcal C Conjugate Vaccine, Biological: TritanrixHepB/Hib, Biological: Polio Sabin Oral Polio Vaccine (GSK) | Arm Label: VeroRab Comparator [5-17M] Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Meningococcal C Conjugate Vaccine, Biological: Cell-culture rabies vaccine | Arm Label: Menjugate Comparator [6-12W] Group; Type: EXPERIMENTAL; Interventions: Biological: Meningococcal C Conjugate Vaccine, Biological: TritanrixHepB/Hib, Biological: Polio Sabin Oral Polio Vaccine (GSK) | Intervention Type: BIOLOGICAL; Name: Malaria Vaccine 257049; Assigned to Arm(s): GSK257049 [5-17M] Group, GSK257049 [6-12W] Group | Intervention Type: BIOLOGICAL; Name: Meningococcal C Conjugate Vaccine; Assigned to Arm(s): GSK257049 [5-17M] Group, GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group, VeroRab Comparator [5-17M] Group | Intervention Type: BIOLOGICAL; Name: Cell-culture rabies vaccine; Assigned to Arm(s): VeroRab Comparator [5-17M] Group | Intervention Type: BIOLOGICAL; Name: TritanrixHepB/Hib; Assigned to Arm(s): GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group | Intervention Type: BIOLOGICAL; Name: Polio Sabin Oral Polio Vaccine (GSK); Assigned to Arm(s): GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group
D: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Systems-level intervention to promote colon cancer screening | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Systems-level intervention to promote colon cancer screening; Assigned to Arm(s): Interventional

Answer: B